Watchlist Price Alert

Foghorn Therapeutics Inc. (FHTX)

NASDAQ: FHTX · Real-Time Price · USD

4.89

0.00 (0.00%)

At close: Jun 24, 2025, 3:59 PM

Foghorn Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-86.62M	-98.43M	-108.88M	-101.32M	-68.8M	-51.13M	-26.34M
Depreciation & Amortization	3.12M	3.45M	3.32M	3.23M	1.33M	693K	379K
Stock-Based Compensation	11.89M	16.19M	14.34M	8.38M	2.96M	1.69M	732K
Other Working Capital	-29.79M	-42.73M	-20.07M	336.48M	28.23M	-14K	1.15M
Other Non-Cash Items	3.47M	2.56M	3.29M	4.61M	4.44M	1.2M	124K
Deferred Income Tax	n/a	n/a	n/a	1.41M	84K	10K	30K
Change in Working Capital	-32.27M	-41.88M	281.55M	33.44M	28.7M	1.2M	2.42M
Operating Cash Flow	-100.41M	-118.11M	193.61M	-50.25M	-31.29M	-46.34M	-22.65M
Capital Expenditures	-906K	-1.22M	-1.21M	-3.31M	-16.18M	-968K	-1.54M
Cash Acquisitions	n/a	n/a	243.11M	-39.49M	250K	4K	n/a
Purchase of Investments	-261.47M	-73.9M	-409.35M	-99.98M	-92.98M	n/a	n/a
Sales Maturities Of Investments	232.47M	219.57M	166.23M	139.47M	-250K	n/a	n/a
Other Investing Acitivies	n/a	n/a	-243.11M	39.49M	250K	4K	n/a
Investing Cash Flow	-29.9M	144.45M	-244.32M	36.17M	-108.91M	-964K	-1.54M
Debt Repayment	n/a	n/a	n/a	-21.2M	4.27M	7.98M	11.14M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	2.03M	1.78M	1.76M	1.42M	1.22M	691K	190K
Financial Cash Flow	105.43M	1.78M	1.76M	22.42M	217.47M	23.97M	51.77M
Net Cash Flow	-24.88M	28.12M	-48.95M	8.34M	77.27M	-23.33M	27.58M
Free Cash Flow	-101.31M	-119.33M	192.4M	-53.56M	-47.47M	-47.3M	-24.19M